FrancophonIA/ELRC3.0 huggingface dataset:
English: Package leaflet: Information for the patient Binocrit 1,000 IU/0.5 mL solution for injection in a pre-filled syringe Binocrit 2,000 IU/1 mL solution for injection in a pre-filled syringe Binocrit 3,000 IU/0.3 mL solution for injection in a pre-filled syringe Binocrit 4,000 IU/0.4 mL solution for injection in a pre-filled syringe Binocrit 5,000 IU/0.5 mL solution for injection in a pre-filled syringe Binocrit 6,000 IU/0.6 mL solution for injection in a pre-filled syringe Binocrit 7,000 IU/0.7 mL solution for injection in a pre-filled syringe Binocrit 8,000 IU/0.8 mL solution for injection in a pre-filled syringe Binocrit 9,000 IU/0.9 mL solution for injection in a pre-filled syringe Binocrit 10,000 IU/1 mL solution for injection in a pre-filled syringe Binocrit 20,000 IU/0.5 mL solution for injection in a pre-filled syringe Binocrit 30,000 IU/0.75 mL solution for injection in a pre-filled syringe Binocrit 40,000 IU/1 mL solution for injection in a pre-filled syringe Epoetin alfa Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
Slovenian: NAVODILO ZA UPORABO Binocrit 1.000 i.e./0,5 ml raztopina za injiciranje v napolnjeni injekcijski brizgi Binocrit 2.000 i.e./1 ml raztopina za injiciranje v napolnjeni injekcijski brizgi Binocrit 3.000 i.e./0,3 ml raztopina za injiciranje v napolnjeni injekcijski brizgi Binocrit 4.000 i.e./0,4 ml raztopina za injiciranje v napolnjeni injekcijski brizgi Binocrit 5.000 i.e./0,5 ml raztopina za injiciranje v napolnjeni injekcijski brizgi Binocrit 6.000 i.e./0,6 ml raztopina za injiciranje v napolnjeni injekcijski brizgi Binocrit 7.000 i.e./0,7 ml raztopina za injiciranje v napolnjeni injekcijski brizgi Binocrit 8.000 i.e./0,8 ml raztopina za injiciranje v napolnjeni injekcijski brizgi Binocrit 9.000 i.e./0,9 ml raztopina za injiciranje v napolnjeni injekcijski brizgi Binocrit 10.000 i.e./1 ml raztopina za injiciranje v napolnjeni injekcijski brizgi Binocrit 20.000 i.e./0,5 ml raztopina za injiciranje v napolnjeni injekcijski brizgi Binocrit 30.000 i.e./0,75 ml raztopina za injiciranje v napolnjeni injekcijski brizgi Binocrit 40.000 i.e./1 ml raztopina za injiciranje v napolnjeni injekcijski brizgi epoetin alfa
English: If you can't take medicines that prevent blood clotting, you must not have Binocrit.
Slovenian: Če ne smete jemati zdravil za preprečevanje nastanka krvnih strdkov,
English: Binocrit should be administered to patients with symptomatic anaemia (e.g. haemoglobin concentration ≤ 10 g/dL (6.2 mmol/L)).
Slovenian: Zdravilo Binocrit se daje bolnikom s simptomatsko anemijo (npr. koncentracijo hemoglobina ≤ 10 g/dl (6,2 mmol/l)).
English: What you need to know before you use Binocrit
Slovenian: Kaj morate vedeti, preden boste uporabili zdravilo Binocrit Ne uporabljajte zdravila Binocrit:
English: Only one dose of Binocrit from each syringe should be taken.
Slovenian: Odmeri se lahko le en odmerek zdravila Binocrit iz vsake brizge.
English: Contents of the pack and other information
Slovenian: Shranjevanje zdravila Binocrit Vsebina pakiranja in dodatne informacije
English: If the haemoglobin concentration is increasing by more than 2 g/dL (1.25 mmol/L) per month, or if the haemoglobin concentration level exceeds 12 g/dL (7.5 mmol/L), reduce the Binocrit dose by about 25 to 50%.
Slovenian: Če se koncentracija hemoglobina zveča za več kot 2 g/dl (1,25 mmol/l) na mesec, ali če raven koncentracije hemoglobina preseže 12 g/dl (7,5 mmol/l), zmanjšajte odmerek zdravila Binocrit za približno 25 do 50 %.
English: - All contraindications associated with autologous blood predonation programmes should be respected in patients being supplemented with Binocrit.
Slovenian: - Pri bolnikih, ki dobivajo zdravilo Binocrit, je treba upoštevati vse kontraindikacije, povezane s preddonorskimi programi avtolognega zbiranja krvi.
English: A major cardiovascular event (death, myocardial infarction, stroke or hospitalisation for congestive heart failure) occurred among 125 (18%) of the 715 patients in the higher haemoglobin group compared to 97 (14%) among the 717 patients in the lower haemoglobin group (hazard ratio [HR] 1.3, 95% CI: 1.0, 1.7, p = 0.03).
Slovenian: 715 bolnikov v skupini z večjim hemoglobinom v primerjavi s 97 (14 %) od 717 bolnikov v skupini z manjšim hemoglobinom (razmerje tveganja [RT] 1,3, 95-% IZ: 1,0; 1,7, p = 0,03).
English: Some patients with more extended dosing intervals (greater than once weekly) of epoetin alfa may not maintain adequate haemoglobin levels (see section 5.1) and may require an increase in epoetin alfa dose.
Slovenian: morda ne bo mogoče vzdrževati ustrezne ravni hemoglobina (glejte poglavje 5.1) in bo treba odmerek epoetina alfa povečati.
English: The starting dose is 50 IU/kg, 2 times per week.
Slovenian: Začetni odmerek je 50 i.e./kg, 2-krat na teden.
English: Take special care with Binocrit:
Slovenian: Pri uporabi zdravila Binocrit bodite posebej previdni:
English: What Binocrit contains - The active substance is: epoetin alfa (for quantity see the table below).
Slovenian: - Učinkovina: epoetin alfa (količine so razvidne iz spodnje preglednice).
English: If the haemoglobin level reaches 15 g/dL (9.38 mmol/L), or higher, during the preoperative period, administration of Binocrit should be stopped and further dosages should not be administered.
Slovenian: Če v obdobju pred kirurškim posegom raven hemoglobina doseže 15 g/dl (9,38 mmol/l) ali več, je treba zdravljenje z zdravilom Binocrit prekiniti.
English: What Binocrit looks like and contents of the pack Binocrit is presented as a clear, colourless solution for injection in a pre-filled syringe.
Slovenian: Zdravilo Binocrit je bistra, brezbarvna raztopina za injiciranje v napolnjeni injekcijski brizgi.
English: Treatment of adult patients with chemotherapy-induced anaemia
Slovenian: Zdravljenje odraslih bolnikov z anemijo, ki je posledica kemoterapije
English: If the haemoglobin is rising by more than 2 g/dL (1.25 mmol/L) per month, or if the sustained haemoglobin exceeds 12 g/dL (7.5 mmol/L) reduce the Binocrit dose by 25%.
Slovenian: Če se hemoglobin zviša za več kot 2 g/dl (1,25 mmol/l) na mesec, ali če stalna vrednost hemoglobina preseže 12 g/dl (7,5 mmol/l), zmanjšajte odmerek zdravila Binocrit za 25 %.
English: This is characterised by a sustained decrease in haemoglobin despite an increase in epoetin alfa dosage (see section 4.8).
Slovenian: Zanjo je značilno trajno zmanjšanje koncentracije hemoglobina kljub povečanju odmerka epoetina alfa
English: “Instructions on how to inject Binocrit yourself” can be found at the end of the package leaflet.
Slovenian: „Navodila za samoinjiciranje zdravila Binocrit“ lahko najdemo na koncu navodila za uporabo.
English: Tell your doctor or nurse immediately if you think too much Binocrit has been injected.
Slovenian: Če ste uporabili večji odmerek zdravila Binocrit, kot bi smeli Takoj obvestite svojega zdravnika ali medicinsko sestro, če mislite, da ste injicirali prevelik odmerek zdravila Binocrit.
English: Do not shake Binocrit syringes.
Slovenian: Injekcijskih brizg z zdravilom Binocrit ne stresajte.
English: Only take one dose of Binocrit from each syringe discarding unwanted solution before injection.
Slovenian: Iz vsake brizge odvzemite samo en odmerek zdravila Binocrit in pred injiciranjem zavrzite preostalo raztopino.
English: If you are a cancer patient be aware that products that stimulate red blood cell production (like Binocrit) may act as a growth factor and therefore in theory may affect the progression of your cancer.
Slovenian: (kot je zdravilo Binocrit), delujejo kot rastni faktor in s tem teoretično vplivajo na napredovanje raka.
English: No evidence exists that indicates that treatment with epoetin alfa alters the metabolism of other medicinal products.
Slovenian: 4.5 Medsebojno delovanje z drugimi zdravili in druge oblike interakcij Ni dokazov, ki kažejo, da zdravljenje z epoetinom alfa vpliva na metabolizem drugih zdravil.
English: Binocrit should be administered by the intravenous route.
Slovenian: Zdravilo Binocrit je treba dati intravensko.
English: Meta-analysis of overall survival data produced a hazard ratio point estimate of 1.06 in favour of controls (95% CI: 1.00, 1.12; 53 trials and 13,933 patients) and for the cancer patients receiving chemotherapy, the overall survival hazard ratio was 1.04 (95% CI: 0.97, 1.11; 38 trials and 10,441 patients).
Slovenian: Za bolnike z rakom, ki so prejemali kemoterapijo, je bilo razmerje tveganja celokupnega preživetja 1,04 (95 % IZ: 0,97; 1,11; 38 preskušanj in 10.441 bolnikov).
English: Baseline Characteristics for Subjects with sEPO < 200 mU/mL at Screening
Slovenian: Izhodiščne značilnosti oseb s sEPO < 200 me./ml ob presejanju Randomizirani
English: If the haemoglobin concentration level exceeds 13 g/dL (8.1 mmol/L), discontinue therapy until it falls below 12 g/dL (7.5 mmol/L) and then reinitiate Binocrit therapy at a dose 25% below the previous dose.
Slovenian: Če raven koncentracije hemoglobina preseže 13 g/dl (8,1 mmol/l), je treba zdravljenje prekiniti, dokler se ne zmanjša pod 12 g/dl (7,5 mmol/l), in nato zdravljenje z zdravilom Binocrit začeti znova z odmerkom, ki je za približno 25 % manjši od predhodnega.
English: If the haemoglobin exceeds 13 g/dL (8.1 mmol/L), discontinue therapy until it falls below 12 g/dL (7.5 mmol/L) and then reinstitute Binocrit therapy at a dose 25% below the previous dose.
Slovenian: Če hemoglobin preseže 13 g/dl (8,1 mmol/l), je treba zdravljenje prekiniti, dokler se ne zmanjša pod 12 g/dl (7,5 mmol/l), in nato zdravljenje nadaljevati z zdravilom Binocrit z odmerkom, ki je 25 % manjši od prejšnjega odmerka.
English: How to store Binocrit
Slovenian: Shranjevanje zdravila Binocrit
English: Store and transport refrigerated (2°C-8°C).
Slovenian: POSEBNA NAVODILA ZA SHRANJEVANJE Zdravilo shranjujte in prevažajte na hladnem (2 °C - 8 °C).
English: INFORMATION IN BRAILLE Binocrit 8,000 IU/0.8 mL
Slovenian: PODATKI V BRAILLOVI PISAVI Binocrit 8.000 i.e./0,8 ml
English: Binocrit 8,000 IU/0.8 mL solution for injection in a pre-filled syringe Each syringe contains 0.8 mL of solution for injection.
Slovenian: Binocrit 8.000 i.e./0,8 ml raztopina za injiciranje v napolnjeni injekcijski brizgi Ena napolnjena injekcijska brizga vsebuje 0,8 ml raztopine za injiciranje.
English: Binocrit should be administered in order to increase haemoglobin to not greater than 12 g/dL (7.5 mmol/L).
Slovenian: Zdravilo Binocrit se daje z namenom zvišati hemoglobin na raven do 12 g/dl (7,5 mmol/l).
English: INFORMATION IN BRAILLE Binocrit 30,000 IU/0.75 mL
Slovenian: PODATKI V BRAILLOVI PISAVI Binocrit 30.000 i.e./0,75 ml
English: INFORMATION IN BRAILLE Binocrit 7,000 IU/0.7 mL
Slovenian: PODATKI V BRAILLOVI PISAVI Binocrit 7.000 i.e./0,7 ml
English: INFORMATION IN BRAILLE Binocrit 9,000 IU/0.9 mL
Slovenian: PODATKI V BRAILLOVI PISAVI Binocrit 9.000 i.e./0,9 ml
English: Binocrit 8,000 IU/0.8 mL solution for injection in a pre-filled syringe
Slovenian: Binocrit 8.000 i.e./0,8 ml raztopina za injiciranje v napolnjeni injekcijski brizgi
English: Binocrit 7,000 IU/0.7 mL solution for injection in a pre-filled syringe Each syringe contains 0.7 mL of solution for injection.
Slovenian: Binocrit 7.000 i.e./0,7 ml raztopina za injiciranje v napolnjeni injekcijski brizgi Ena napolnjena injekcijska brizga vsebuje 0,7 ml raztopine za injiciranje.
English: Binocrit 8,000 IU/0.8 mL solution for injection in a pre-filled syringe EU/1/07/410/013
Slovenian: Binocrit 8.000 i.e./0,8 ml raztopina za injiciranje v napolnjeni injekcijski brizgi EU/1/07/410/013
English: Binocrit 9,000 IU/0.9 mL solution for injection in a pre-filled syringe
Slovenian: Binocrit 9.000 i.e./0,9 ml raztopina za injiciranje v napolnjeni injekcijski brizgi
English: Binocrit 7,000 IU/0.7 mL solution for injection in a pre-filled syringe
Slovenian: Binocrit 7.000 i.e./0,7 ml raztopina za injiciranje v napolnjeni injekcijski brizgi
English: Binocrit 9,000 IU/0.9 mL solution for injection in a pre-filled syringe Each syringe contains 0.9 mL of solution for injection.
Slovenian: Binocrit 9.000 i.e./0,9 ml raztopina za injiciranje v napolnjeni injekcijski brizgi Ena napolnjena injekcijska brizga vsebuje 0,9 ml raztopine za injiciranje.
English: The use of Binocrit in patients scheduled for major elective orthopaedic surgery and not participating in an autologous blood predonation programme is contraindicated in patients with severe coronary, peripheral arterial, carotid or cerebral vascular disease, including patients with recent myocardial infarction or cerebral vascular accident.
Slovenian: Pri bolnikih, naročenih na večji elektivni ortopedski kirurški poseg in ki niso vključeni v program avtolognega zbiranja krvi, je uporaba zdravila Binocrit kontraindicirana, če imajo hudo koronarno,
English: INFORMATION IN BRAILLE Binocrit 6,000 IU/0.6 mL
Slovenian: PODATKI V BRAILLOVI PISAVI Binocrit 6.000 i.e./0,6 ml
English: INFORMATION IN BRAILLE Binocrit 40,000 IU/1 mL
Slovenian: PODATKI V BRAILLOVI PISAVI Binocrit 40.000 i.e./1 ml
English: Binocrit 30,000 IU/0.75 mL solution for injection in a pre-filled syringe Each syringe contains 0.75 mL of solution for injection.
Slovenian: Binocrit 30.000 i.e./0,75 ml raztopina za injiciranje v napolnjeni injekcijski brizgi Ena napolnjena injekcijska brizga vsebuje 0,75 ml raztopine za injiciranje.
English: Binocrit 2,000 IU/1 mL solution for injection in a pre-filled syringe Each mL of solution contains 2,000 IU of epoetin alfa* corresponding to 16.8 micrograms per mL
Slovenian: Binocrit 2.000 i.e./1 ml raztopina za injiciranje v napolnjeni injekcijski brizgi En ml raztopine vsebuje 2.000 i.e. epoetina alfa*, kar ustreza 16,8 mikrogramov na ml. 1 ml napolnjena injekcijska brizga vsebuje 2.000 mednarodnih enot (i.e.), kar ustreza 16,8 mikrogramov epoetina alfa.
English: INFORMATION IN BRAILLE Binocrit 4,000 IU/0.4 mL
Slovenian: PODATKI V BRAILLOVI PISAVI Binocrit 4.000 i.e./0,4 ml
English: Binocrit 40,000 IU/1 mL solution for injection in a pre-filled syringe Each mL of solution contains 40,000 IU of epoetin alfa* corresponding to 336.0 micrograms per mL
Slovenian: Binocrit 40.000 i.e./1 ml raztopina za injiciranje v napolnjeni injekcijski brizgi En ml raztopine vsebuje 40.000 i.e. epoetina alfa*, kar ustreza 336,0 mikrogramov na ml. 1 ml napolnjena injekcijska brizga vsebuje 40.000 mednarodnih enot (i.e.), kar ustreza 336,0 mikrogramov epoetina alfa.
English: Binocrit 6,000 IU/0.6 mL solution for injection in a pre-filled syringe
Slovenian: Binocrit 6.000 i.e./0,6 ml raztopina za injiciranje v napolnjeni injekcijski brizgi
English: Binocrit 30,000 IU/0.75 mL solution for injection in a pre-filled syringe Epoetin alfa
Slovenian: Binocrit 30.000 i.e./0,75 ml raztopina za injiciranje v napolnjeni injekcijski brizgi
English: - in adults and children aged 1 to 18 years on haemodialysis and adult patients on peritoneal dialysis (see section 4.4).
Slovenian: Zdravilo Binocrit je indicirano za zdravljenje simptomatske anemije, povezane s kronično ledvično odpovedjo: - pri odraslih in otrocih, starih 1 do 18 let, ki se zdravijo s hemodializo, in odraslih bolnikih, ki se zdravijo s peritonealno dializo (glejte poglavje 4.4).
English: Binocrit 30,000 IU/0.75 mL solution for injection in a pre-filled syringe EU/1/07/410/023
Slovenian: Binocrit 30.000 i.e./0,75 ml raztopina za injiciranje v napolnjeni injekcijski brizgi EU/1/07/410/023
English: Sodium dihydrogen phosphate dihydrate Disodium phosphate dihydrate Sodium chloride
Slovenian: 6.1 Seznam pomožnih snovi natrijev dihidrogenfosfat dihidrat dinatrijev fosfat dihidrat natrijev klorid glicin polisorbat 80 voda za injekcije klorovodikova kislina (za uravnavanje pH) natrijev hidroksid (za uravnavanje pH)
English: Binocrit 6,000 IU/0.6 mL solution for injection in a pre-filled syringe Each syringe contains 0.6 mL of solution for injection.
Slovenian: Binocrit 6.000 i.e./0,6 ml raztopina za injiciranje v napolnjeni injekcijski brizgi Ena napolnjena injekcijska brizga vsebuje 0,6 ml raztopine za injiciranje.
English: Binocrit 6,000 IU/0.6 mL solution for injection in a pre-filled syringe EU/1/07/410/011
Slovenian: Binocrit 6.000 i.e./0,6 ml raztopina za injiciranje v napolnjeni injekcijski brizgi EU/1/07/410/011
English: INFORMATION IN BRAILLE Binocrit 5,000 IU/0.5 mL
Slovenian: PODATKI V BRAILLOVI PISAVI Binocrit 5.000 i.e./0,5 ml
English: INFORMATION IN BRAILLE Binocrit 20,000 IU/0.5 mL
Slovenian: PODATKI V BRAILLOVI PISAVI Binocrit 20.000 i.e./0,5 ml
English: Binocrit 4,000 IU/0.4 mL solution for injection in a pre-filled syringe Each syringe contains 0.4 mL of solution for injection.
Slovenian: Binocrit 4.000 i.e./0,4 ml raztopina za injiciranje v napolnjeni injekcijski brizgi Ena napolnjena injekcijska brizga vsebuje 0,4 ml raztopine za injiciranje.
English: Binocrit 9,000 IU/0.9 mL solution for injection in a pre-filled syringe EU/1/07/410/019
Slovenian: Binocrit 9.000 i.e./0,9 ml raztopina za injiciranje v napolnjeni injekcijski brizgi EU/1/07/410/019
English: Randomised
Slovenian: občasni
English: In healthy subjects, a dose-proportional increase in serum epoetin alfa concentrations was observed after intravenous administration of 150 and 300 IU/kg, 3 times per week.
Slovenian: Pri zdravih osebah so po intravenskem dajanju 150 in 300 i.e./kg 3-krat na teden opazili z odmerkom sorazmerno povečanje koncentracij epoetina alfa v serumu.
English: Binocrit 4,000 IU/0.4 mL solution for injection in a pre-filled syringe
Slovenian: Binocrit 4.000 i.e./0,4 ml raztopina za injiciranje v napolnjeni injekcijski brizgi
English: INFORMATION IN BRAILLE Binocrit 2,000 IU/1 mL
Slovenian: PODATKI V BRAILLOVI PISAVI Binocrit 2.000 i.e./1 ml
English: In paediatric patients the recommended haemoglobin concentration range is between 9.5 g/dL to 11 g/dL (5.9 to 6.8 mmol/L).
Slovenian: Pri pediatričnih bolnikih je priporočeni razpon koncentracije hemoglobina med 9,5 g/dl in 11 g/dl
English: INFORMATION IN BRAILLE Binocrit 3,000 IU/0.3 mL
Slovenian: PODATKI V BRAILLOVI PISAVI Binocrit 3.000 i.e./0,3 ml
English: In addition, special precaution should be taken in patients with predisposition for development of DVTs.
Slovenian: Poleg tega je pri bolnikih s predispozicijo za nastanek globoke venske tromboze (DVT
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Binocrit 30,000 IU/0.75 mL injection
Slovenian: IME ZDRAVILA IN POT(I) UPORABE Binocrit 30.000 i.e./0,75 ml injekcija epoetin alfa i.v./s.c.
English: Binocrit 7,000 IU/0.7 mL solution for injection in a pre-filled syringe EU/1/07/410/017
Slovenian: Binocrit 7.000 i.e./0,7 ml raztopina za injiciranje v napolnjeni injekcijski brizgi EU/1/07/410/017
English: Binocrit 5,000 IU/0.5 mL solution for injection in a pre-filled syringe Each syringe contains 0.5 mL of solution for injection.
Slovenian: Binocrit 5.000 i.e./0,5 ml raztopina za injiciranje v napolnjeni injekcijski brizgi Ena napolnjena injekcijska brizga vsebuje 0,5 ml raztopine za injiciranje.
English: INFORMATION IN BRAILLE Binocrit 1,000 IU/0.5 mL
Slovenian: PODATKI V BRAILLOVI PISAVI Binocrit 1.000 i.e./0,5 ml
English: Binocrit 5,000 IU/0.5 mL solution for injection in a pre-filled syringe EU/1/07/410/009
Slovenian: Binocrit 5.000 i.e./0,5 ml raztopina za injiciranje v napolnjeni injekcijski brizgi EU/1/07/410/009
English: Binocrit 5,000 IU/0.5 mL solution for injection in a pre-filled syringe Each mL of solution contains 10,000 IU of epoetin alfa* corresponding to 84.0 micrograms per mL
Slovenian: Binocrit 5.000 i.e./0,5 ml raztopina za injiciranje v napolnjeni injekcijski brizgi En ml raztopine vsebuje 10.000 i.e. epoetina alfa*, kar ustreza 84,0 mikrogramov na ml. 0,5 ml napolnjena injekcijska brizga vsebuje 5.000 mednarodnih enot (i.e.), kar ustreza 42,0 mikrogramov epoetina alfa.
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Binocrit 7,000 IU/0.7 mL injection
Slovenian: IME ZDRAVILA IN POT(I) UPORABE Binocrit 7.000 i.e./0,7 ml injekcija epoetin alfa i.v./s.c.
English: If after an additional 4 weeks of therapy at 300 IU/kg 3 times per week, the haemoglobin concentration has increased ≥ 1 g/dL (≥ 0.62 mmol/L) or the reticulocyte count has increased ≥ 40,000 cells/µL, the dose should remain at 300 IU/kg 3 times per week.
Slovenian: krat na teden, koncentracija hemoglobina zvečala za ≥ 1 g/dl (≥ 0,62 mmol/l) in se je število retikulocitov zvečalo za ≥ 40.000 celic/µl nad izhodiščno vrednost, naj odmerek ostane
English: per week.
Slovenian: 4 tedne
English: Binocrit 5,000 IU/0.5 mL solution for injection in a pre-filled syringe
Slovenian: Binocrit 5.000 i.e./0,5 ml raztopina za injiciranje v napolnjeni injekcijski brizgi
English: Binocrit 4,000 IU/0.4 mL solution for injection in a pre-filled syringe EU/1/07/410/007
Slovenian: Binocrit 4.000 i.e./0,4 ml raztopina za injiciranje v napolnjeni injekcijski brizgi EU/1/07/410/007
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Binocrit 9,000 IU/0.9 mL injection
Slovenian: IME ZDRAVILA IN POT(I) UPORABE Binocrit 9.000 i.e./0,9 ml injekcija epoetin alfa i.v./s.c.
English: Binocrit 20,000 IU/0.5 mL solution for injection in a pre-filled syringe EU/1/07/410/021
Slovenian: Binocrit 20.000 i.e./0,5 ml raztopina za injiciranje v napolnjeni injekcijski brizgi EU/1/07/410/021
English: Binocrit should not be used:
Slovenian: zdravila Binocrit ne smete uporabljati.
English: INFORMATION IN BRAILLE Binocrit 10,000 IU/1 mL
Slovenian: PODATKI V BRAILLOVI PISAVI Binocrit 10.000 i.e./1 ml
English: Binocrit 30,000 IU/0.75 mL solution for injection in a pre-filled syringe Each mL of solution contains 40,000 IU of epoetin alfa* corresponding to 336.0 micrograms per mL
Slovenian: Binocrit 30.000 i.e./0,75 ml raztopina za injiciranje v napolnjeni injekcijski brizgi En ml raztopine vsebuje 40.000 i.e. epoetina alfa*, kar ustreza 336,0 mikrogramov na ml. 0,75 ml napolnjena injekcijska brizga vsebuje 30.000 mednarodnih enot (i.e.), kar ustreza 252,0 mikrogramov epoetina alfa.
English: Binocrit 40,000 IU/1 mL solution for injection in a pre-filled syringe EU/1/07/410/025
Slovenian: Binocrit 40.000 i.e./1 ml raztopina za injiciranje v napolnjeni injekcijski brizgi EU/1/07/410/025
English: Binocrit 7,000 IU/0.7 mL solution for injection in a pre-filled syringe Each mL of solution contains 10,000 IU of epoetin alfa* corresponding to 84.0 micrograms per mL
Slovenian: Binocrit 7.000 i.e./0,7 ml raztopina za injiciranje v napolnjeni injekcijski brizgi En ml raztopine vsebuje 10.000 i.e. epoetina alfa*, kar ustreza 84,0 mikrogramov na ml. 0,7 ml napolnjena injekcijska brizga vsebuje 7.000 mednarodnih enot (i.e.), kar ustreza 58,8 mikrogramov epoetina alfa.
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Binocrit 8,000 IU/0.8 mL injection
Slovenian: IME ZDRAVILA IN POT(I) UPORABE Binocrit 8.000 i.e./0,8 ml injekcija epoetin alfa i.v./s.c.
English: Binocrit 3,000 IU/0.3 mL solution for injection in a pre-filled syringe Each syringe contains 0.3 mL of solution for injection.
Slovenian: Binocrit 3.000 i.e./0,3 ml raztopina za injiciranje v napolnjeni injekcijski brizgi Ena napolnjena injekcijska brizga vsebuje 0,3 ml raztopine za injiciranje.
English: Binocrit 2,000 IU/1 mL solution for injection in a pre-filled syringe EU/1/07/410/003
Slovenian: Binocrit 2.000 i.e./1 ml raztopina za injiciranje v napolnjeni injekcijski brizgi EU/1/07/410/003
English: Binocrit 3,000 IU/0.3 mL solution for injection in a pre-filled syringe EU/1/07/410/005
Slovenian: Binocrit 3.000 i.e./0,3 ml raztopina za injiciranje v napolnjeni injekcijski brizgi EU/1/07/410/005
English: Binocrit 3,000 IU/0.3 mL solution for injection in a pre-filled syringe
Slovenian: Binocrit 3.000 i.e./0,3 ml raztopina za injiciranje v napolnjeni injekcijski brizgi
English: Binocrit 1,000 IU/0.5 mL solution for injection in a pre-filled syringe
Slovenian: Binocrit 1.000 i.e./0,5 ml raztopina za injiciranje v napolnjeni injekcijski brizgi
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Binocrit 4,000 IU/0.4 mL injection
Slovenian: IME ZDRAVILA IN POT(I) UPORABE Binocrit 4.000 i.e./0,4 ml injekcija epoetin alfa i.v./s.c.